Supplemental Cash Flow Information (Details) - Schedule of supplemental cash flow Information - USD ($) |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2022 |
Dec. 31, 2021 |
Dec. 31, 2020 |
|
Non-cash investing and financing activities: | |||
Contribution benefit on low interest rate notes | $ 170,329 | ||
Shares issued to acquire Holdco shares | 11,441 | ||
Shares issued in connection with Xcite acquisition | 4,196 | ||
Common shares issued to settle debt | 107,671 | ||
Deferred financing costs included in accrued expenses | 174,813 | 398,276 | |
Fair value common shares issued in acquisition | $ 13,184,384 |
X | ||||||||||
- Definition The amount of instruments issued by the entity that represent indebtedness. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The amount of finance costs that the entity does not separately disclose in the same statement or note. [Refer: Finance costs] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Contribution benefit on low interest rate notes (Note 9). No definition available.
|
X | ||||||||||
- Definition Amount of fair value of broker warrants. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Shares issued in connection with Xcite acquisition. No definition available.
|
X | ||||||||||
- References No definition available.
|